Menu

Virus Delays Stir Deadline Concerns in Generic Drug Patent Cases

Bloomberg Law

"New coronavirus-related disruptions to federal courts are causing attorneys’ concerns about meeting tight deadlines unique to generic drug patent disputes."

Read the article

Related Contacts
Jonathan Davies  Partner Washington, DC